XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2018
Mar. 31, 2018
Mar. 31, 2017
CURRENT ASSETS      
Cash $ 5,078,605 $ 6,974,070 $ 1,559,701
Accounts receivable 0 74,813 0
Prepaid expenses and other current assets 89,343 181,367 37,551
TOTAL CURRENT ASSETS 5,167,948 7,230,250 1,597,252
Property and equipment, net 16,094 27,552 29,223
Patents, net 71,250 75,832 84,996
Deposits 17,131 18,270 14,897
TOTAL ASSETS 5,272,423 7,351,904 1,726,368
CURRENT LIABILITIES      
Accounts payable 91,879 124,450 484,423
Due to related parties 98,866 90,366 57,866
Convertible notes payable, net 901,727 0  
Other current liabilities 168,356 263,141 69,467
TOTAL CURRENT LIABILITIES 1,260,828 477,957 611,756
Convertible notes payable, net 0 841,153 519,200
TOTAL LIABILITIES 1,260,828 1,319,110 1,130,956
COMMITMENTS AND CONTINGENCIES (Note 12) (Note 13 as of 9/30/18)  
STOCKHOLDERS' EQUITY      
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2018 and 2017; 17,739,511 and 8,797,086 issued and outstanding at March 31, 2018 and 2017, respectively 17,835 17,740 8,796
Additional paid-in capital 106,107,157 105,574,014 94,445,739
Accumulated deficit (101,997,287) (99,457,714) (93,778,156)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS 4,127,705 6,134,040 676,379
NONCONTROLLING INTERESTS (116,110) (101,246) (80,967)
TOTAL STOCKHOLDERS' EQUITY 4,011,595 6,032,794 595,412
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,272,423 $ 7,351,904 $ 1,726,368